During the past decade, Covance Clinical Research Inc conducted 91 clinical trials. In the 10-year time frame, 91 clinical trials started and 39 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 25 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Covance Clinical Research Inc" #1 sponsor was "Eli Lilly and Company" with 48 trials, followed by "Amgen" with 6 trials sponsored, "Loxo Oncology, Inc." with 5 trials sponsored, "MedImmune LLC" with 5 trials sponsored and "Pfizer" with 5 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Covance Clinical Research Inc" #1 collaborator was "Covance" with 9 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator, "Department of Health and Human Services" with 2 trials as a collaborator, "Loxo Oncology, Inc." with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Covance Clinical Research Inc" are "Healthy" (53 trials), "Healthy Volunteers" (7 trials), "Healthy Participants" (6 trials), "Healthy Subjects" (6 trials) and "Rheumatoid Arthritis" (5 trials). Many other conditions were trialed in "Covance Clinical Research Inc" in a lesser frequency.

Most popular intervention types in "Covance Clinical Research Inc" are "Drug" (100 trials), "Biological" (14 trials), "Other" (5 trials), "Device" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "Itraconazole" (6 trials), "Lasmiditan" (6 trials), "AMG 510" (4 trials) and "Midazolam" (4 trials). Other intervention names were less common.

The vast majority of trials in "Covance Clinical Research Inc" are 101 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Covance Clinical Research Inc". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 99 completed trials in Covance Clinical Research Inc, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Covance Clinical Research Inc, 90 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 0 trials that are defined as “Not Applicable".